Effectiveness of Conservative Treatment in Patients With Thoracic and Lumbar Fractures Without Neurological Deficit
Prospective Cohort Study of the Effectiveness of Conservative Treatment in Patients With AOSpine Type A2 and A3 Fractures of the Thoracic and Lumbar Spine Without Neurological Deficit
1 other identifier
observational
40
1 country
2
Brief Summary
The goal of this observational study is to compare the long-term clinical outcomes of two treatment methods (conservative therapy and surgical treatment) in patients with fractures of the thoracic and lumbar spine without neurological deficit
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2023
CompletedFirst Posted
Study publicly available on registry
September 29, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2025
CompletedOctober 3, 2025
September 1, 2025
11 months
September 22, 2023
September 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oswestry Disability Index
This questionnaire allows for a precise numeric assessment of the extent to which an individual's daily functioning is affected by back pain and objectively demonstrates the clinical outcome of the provided treatment. The scale will be applied at all stages of the study, starting from the initial examination and concluding with the follow-up examination one year after intervention. The questionnaire consists of 10 sections, each containing 6 statements. Depending on the response, a score from 0 to 5 is assigned. The maximum total score is 50. Subsequently, the scores are converted into percentages, ranging from 0 to 100%. If one of the sections is not applicable or omitted for ethical reasons, the sum of scores from the remaining 9 sections is divided by 45 to calculate the percentage.
admission, 3, 6 and 12 months
Secondary Outcomes (5)
The SF-36 v.1 (Standard Form)
admission, 3, 6 and 12 months
EQ-5D-5L
admission, 3, 6 and 12 months
ASA
admission
Rivermead Mobility Index
1, 3, 6 and 12 months
Lovett's muscle testing
1, 3, 6 and 12 months
Study Arms (2)
Conservative treatment group
The main group (prospective) will consist of patients who received conservative therapy. The expected number of observations in the main group will be 50 patients.
Surgical treatment group
The control group (historical control) will be comprised of 50 patients who underwent surgery previously at the Sklifosovsky Research Institute for Emergency Medicine.
Interventions
3-month immobilization period, hyperextension braces for specific fractures, therapeutic exercises, and gradual activity restoration.
Pedicle screw fixation or fusion; anterior plate fusion
Eligibility Criteria
All participants in the study are patients with spinal fractures who arrived through the emergency medical services and were urgently admitted to the hospital.
You may qualify if:
- Patients aged 18 to 65 years.
- Isolated fracture of a single thoracic or lumbar vertebra, classified as type A2 or A3 according to the AOSpine classification.
- Absence of clinical evidence of nerve root or spinal cord compression at the injury level.
- Degree of spinal canal space narrowing less than 50% based on CT scans.
- Informed consent to participate in the study.
You may not qualify if:
- Sagittal imbalance (Type 4 by C. Barrey).
- Vertebral bone density at the injury level less than 100 HU or osteoporosis exceeding grade 3 in vertebral bodies, pelvic bones, and limbs.
- Previous spinal surgeries.
- Anesthesia risk of 4 or 5 according to ASA.
- Acute exacerbation and decompensation of somatic diseases.
- Malignant tumors at any site.
- Systemic connective tissue disorders.
- Cognitive impairments hindering patient communication.
- Floating and mural thrombosis, regardless of location.
- Newly identified and uncorrectable cardiac rhythm disorders.
- Dizziness.
- Consequences of a previous acute cerebrovascular event.
- Pregnancy at any stage.
- Acute infectious diseases.
- History of fractures of the pelvis, lower limbs, or vertebral bodies.
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Sklifosovsky Research Institute for Emergency Medicine
Moscow, 107045, Russia
Moscow Scientific and Practical Center for Medical Rehabilitation, Restorative and Sports Medicine
Moscow, 111674, Russia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Andrey Grin, MD, PhD
Sklifosovsky Research Institute for Emergency Medicine
- STUDY DIRECTOR
Aleksandr Talypov, MD, PhD
Sklifosovsky Research Institute for Emergency Medicine
- PRINCIPAL INVESTIGATOR
Vasiliy Karanadze, MD, PhD
Sklifosovsky Research Institute for Emergency Medicine
- PRINCIPAL INVESTIGATOR
Ivan Lvov, MD, PhD
Sklifosovsky Research Institute for Emergency Medicine
- PRINCIPAL INVESTIGATOR
Anton Kordonskiy, MD, PhD
Sklifosovsky Research Institute for Emergency Medicine
- STUDY CHAIR
Iren Pogonchenkova, MD, PhD
Moscow Scientific and Practical Center for Medical Rehabilitation, Restorative and Sports Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- neurosurgeon
Study Record Dates
First Submitted
September 22, 2023
First Posted
September 29, 2023
Study Start
November 1, 2023
Primary Completion
October 1, 2024
Study Completion
September 29, 2025
Last Updated
October 3, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
All the obtained data will be stored in the data centre of the Sklifosovsky Research Institute for Emergency Medicine. These data will be unavailable to all parties until the final analysis.